Gaetano Scotto
Clinic of Infectious Diseases
University of Foggia
Foggia
Italy
Name/email consistency: high
- Early and sustained virological response in non-responders with chronic hepatitis C: a randomized open-label study of pegylated interferon-alpha-2a versus pegylated interferon-alpha-2b. Scotto, G., Fazio, V., Fornabaio, C., Tartaglia, A., Di Tullio, R., Saracino, A., Angarano, G. Drugs (2008)
- Peginterferon alfa-2b treatment for patients affected by acute hepatitis C: presentation of six case reports. Scotto, G., Palumbo, E., Fazio, V., Cibelli, D.C., Saracino, A., Angarano, G. Infection (2005)
- Interferon-alpha (IFN alpha) daily dose versus IFN alpha plus ribavirin for treatment-naive chronic hepatitis c patients infected by genotype 1b. Scotto, G., Campanozzi, F., D'Adduzio, A., Grimaldi, M., Fazio, V. BioDrugs (2003)
- Association between HLA class II antigens and hepatitis C virus infection. Scotto, G., Fazio, V., D'Alessandro, G., Monno, L., Saracino, A., Palumbo, E., Angarano, G. J. Biol. Regul. Homeost. Agents (2003)









